메뉴 건너뛰기




Volumn 6, Issue 25, 2015, Pages 21379-21394

Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action

Author keywords

Ginsenoside; MDM2; Molecular targeting efficiency; Oral delivery; PEG PLGA nanoparticles

Indexed keywords

GINSENOSIDE; NANOPARTICLE; ANTINEOPLASTIC AGENT; DRUG CARRIER; GINSENOSIDE 25-OCH3-PPD; MACROGOL DERIVATIVE; MDM2 PROTEIN, HUMAN; POLYESTER; POLYETHYLENE GLYCOL-POLY(LACTIDE-CO-GLYCOLIDE); PROTEIN MDM2; PROTEIN P53; TP53 PROTEIN, HUMAN;

EID: 84940755759     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4091     Document Type: Article
Times cited : (59)

References (52)
  • 2
    • 84896402409 scopus 로고    scopus 로고
    • Natural products as lead structures: chemical transformations to create lead-like libraries
    • Pascolutti M, Quinn RJ. Natural products as lead structures: chemical transformations to create lead-like libraries. Drug Discov Today. 2014; 19:215-221.
    • (2014) Drug Discov Today , vol.19 , pp. 215-221
    • Pascolutti, M.1    Quinn, R.J.2
  • 3
    • 84964282316 scopus 로고    scopus 로고
    • Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview
    • Wong AS, Che CM, Leung KW. Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview. Nat Prod Rep. 2015; 32:256-272.
    • (2015) Nat Prod Rep , vol.32 , pp. 256-272
    • Wong, A.S.1    Che, C.M.2    Leung, K.W.3
  • 4
    • 84865039191 scopus 로고    scopus 로고
    • Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure-Activity Relationships, and Molecular Mechanisms of Action
    • Nag SA, Qin JJ, Wang W, Wang MH, Wang H, Zhang R. Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure-Activity Relationships, and Molecular Mechanisms of Action. Front Pharmacol. 2012; 3:25.
    • (2012) Front Pharmacol , vol.3 , pp. 25
    • Nag, S.A.1    Qin, J.J.2    Wang, W.3    Wang, M.H.4    Wang, H.5    Zhang, R.6
  • 5
    • 33847104559 scopus 로고    scopus 로고
    • In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng
    • Wang W, Zhao Y, Rayburn ER, Hill DL, Wang H, Zhang R. In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother Pharmacol. 2007; 59:589-601.
    • (2007) Cancer Chemother Pharmacol , vol.59 , pp. 589-601
    • Wang, W.1    Zhao, Y.2    Rayburn, E.R.3    Hill, D.L.4    Wang, H.5    Zhang, R.6
  • 6
    • 33846068859 scopus 로고    scopus 로고
    • Isolation, structural determination, and evaluation of the biological activity of 20(s)-25-methoxyl-dammarane-3beta, 12beta, 20-triol [20(s)-25-OCH3-PPD], a novel natural product from Panax notoginseng
    • Zhao Y, Wang W, Han L, Rayburn ER, Hill DL, Wang H, Zhang R. Isolation, structural determination, and evaluation of the biological activity of 20(s)-25-methoxyl-dammarane-3beta, 12beta, 20-triol [20(s)-25-OCH3-PPD], a novel natural product from Panax notoginseng. Med Chem. 2007; 3:51-60.
    • (2007) Med Chem , vol.3 , pp. 51-60
    • Zhao, Y.1    Wang, W.2    Han, L.3    Rayburn, E.R.4    Hill, D.L.5    Wang, H.6    Zhang, R.7
  • 8
    • 64649094642 scopus 로고    scopus 로고
    • Novel ginsenosides 25-OH-PPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of action
    • Wang W, Rayburn ER, Zhao Y, Wang H, Zhang R. Novel ginsenosides 25-OH-PPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of action. Cancer Lett. 2009; 278:241-248.
    • (2009) Cancer Lett , vol.278 , pp. 241-248
    • Wang, W.1    Rayburn, E.R.2    Zhao, Y.3    Wang, H.4    Zhang, R.5
  • 9
    • 84864188733 scopus 로고    scopus 로고
    • Natural product ginsenoside 25-OCH3-PPD inhibits breast cancer growth and metastasis through down-regulating MDM2
    • Wang W, Zhang X, Qin JJ, Voruganti S, Nag SA, Wang MH, Wang H, Zhang R. Natural product ginsenoside 25-OCH3-PPD inhibits breast cancer growth and metastasis through down-regulating MDM2. PLoS One. 2012; 7:e41586.
    • (2012) PLoS One , vol.7
    • Wang, W.1    Zhang, X.2    Qin, J.J.3    Voruganti, S.4    Nag, S.A.5    Wang, M.H.6    Wang, H.7    Zhang, R.8
  • 10
    • 39449132110 scopus 로고    scopus 로고
    • 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action
    • Wang W, Wang H, Rayburn ER, Zhao Y, Hill DL, Zhang R. 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action. Br J Cancer. 2008; 98:792-802.
    • (2008) Br J Cancer , vol.98 , pp. 792-802
    • Wang, W.1    Wang, H.2    Rayburn, E.R.3    Zhao, Y.4    Hill, D.L.5    Zhang, R.6
  • 11
    • 45349085085 scopus 로고    scopus 로고
    • Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides
    • Wang W, Rayburn ER, Hao M, Zhao Y, Hill DL, Zhang R, Wang H. Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides. Prostate. 2008; 68:809-819.
    • (2008) Prostate , vol.68 , pp. 809-819
    • Wang, W.1    Rayburn, E.R.2    Hao, M.3    Zhao, Y.4    Hill, D.L.5    Zhang, R.6    Wang, H.7
  • 13
    • 0141482040 scopus 로고    scopus 로고
    • Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy
    • Zhang Z, Li M, Wang H, Agrawal S, Zhang R. Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy. Proc Natl Acad Sci U S A. 2003; 100:11636-11641.
    • (2003) Proc Natl Acad Sci U S A , vol.100 , pp. 11636-11641
    • Zhang, Z.1    Li, M.2    Wang, H.3    Agrawal, S.4    Zhang, R.5
  • 15
    • 53049108040 scopus 로고    scopus 로고
    • Targeting the MDM2-p53 interaction for cancer therapy
    • Shangary S, Wang S. Targeting the MDM2-p53 interaction for cancer therapy. Clin Cancer Res. 2008; 14:5318-5324.
    • (2008) Clin Cancer Res , vol.14 , pp. 5318-5324
    • Shangary, S.1    Wang, S.2
  • 16
    • 84867458226 scopus 로고    scopus 로고
    • Small molecule agents targeting the p53-MDM2 pathway for cancer therapy
    • Wang W, Hu Y. Small molecule agents targeting the p53-MDM2 pathway for cancer therapy. Med Res Rev. 2012; 32:1159-1196.
    • (2012) Med Res Rev , vol.32 , pp. 1159-1196
    • Wang, W.1    Hu, Y.2
  • 18
    • 84871336793 scopus 로고    scopus 로고
    • Natural Product MDM2 Inhibitors: Anticancer Activity and Mechanisms of Action
    • Qin JJ, Nag S, Voruganti S, Wang W, Zhang R. Natural Product MDM2 Inhibitors: Anticancer Activity and Mechanisms of Action. Current Medicinal Chemistry. 2012; 19:5705-5725.
    • (2012) Current Medicinal Chemistry , vol.19 , pp. 5705-5725
    • Qin, J.J.1    Nag, S.2    Voruganti, S.3    Wang, W.4    Zhang, R.5
  • 28
    • 84923301338 scopus 로고    scopus 로고
    • Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation
    • Qin JJ, Wang W, Voruganti S, Wang H, Zhang WD, Zhang R. Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation. Oncotarget. 2015; 6:2623-2640.
    • (2015) Oncotarget , vol.6 , pp. 2623-2640
    • Qin, J.J.1    Wang, W.2    Voruganti, S.3    Wang, H.4    Zhang, W.D.5    Zhang, R.6
  • 29
    • 69249208641 scopus 로고    scopus 로고
    • Pharmacokinetics of 20(s)-25-methoxyl-dammarane-3beta, 12beta, 20-triol and its active metabolite after oral and intravenous administration in rat
    • Zhang X, Xu J, Zhang D, Gu J, Zhao Y. Pharmacokinetics of 20(s)-25-methoxyl-dammarane-3beta, 12beta, 20-triol and its active metabolite after oral and intravenous administration in rat. Xenobiotica. 2009; 39:457-464.
    • (2009) Xenobiotica , vol.39 , pp. 457-464
    • Zhang, X.1    Xu, J.2    Zhang, D.3    Gu, J.4    Zhao, Y.5
  • 30
    • 84896888106 scopus 로고    scopus 로고
    • Self-microemulsifying drug-delivery system for improved oral bioavailability of 20(s)-25-methoxyl-dammarane-3beta, 12beta, 20-triol: preparation and evaluation
    • Cai S, Shi CH, Zhang X, Tang X, Suo H, Yang L, Zhao Y. Self-microemulsifying drug-delivery system for improved oral bioavailability of 20(s)-25-methoxyl-dammarane-3beta, 12beta, 20-triol: preparation and evaluation. Int J Nanomedicine. 2014; 9:913-920.
    • (2014) Int J Nanomedicine , vol.9 , pp. 913-920
    • Cai, S.1    Shi, C.H.2    Zhang, X.3    Tang, X.4    Suo, H.5    Yang, L.6    Zhao, Y.7
  • 32
    • 84859719708 scopus 로고    scopus 로고
    • Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers
    • Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev. 2012; 64:557-570.
    • (2012) Adv Drug Deliv Rev , vol.64 , pp. 557-570
    • Ensign, L.M.1    Cone, R.2    Hanes, J.3
  • 33
    • 84872401360 scopus 로고    scopus 로고
    • A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics
    • Steichen SD, Caldorera-Moore M, Peppas NA. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. Eur J Pharm Sci. 2013; 48:416-427.
    • (2013) Eur J Pharm Sci , vol.48 , pp. 416-427
    • Steichen, S.D.1    Caldorera-Moore, M.2    Peppas, N.A.3
  • 34
    • 80054804587 scopus 로고    scopus 로고
    • Solid lipid nanoparticles: an oral bioavailability enhancer vehicle
    • Harde H, Das M, Jain S. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin Drug Deliv. 2011; 8:1407-1424.
    • (2011) Expert Opin Drug Deliv , vol.8 , pp. 1407-1424
    • Harde, H.1    Das, M.2    Jain, S.3
  • 36
    • 70449637229 scopus 로고    scopus 로고
    • Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo
    • Anand P, Nair HB, Sung B, Kunnumakkara AB, Yadav VR, Tekmal RR, Aggarwal BB. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol. 2010; 79:330-338.
    • (2010) Biochem Pharmacol , vol.79 , pp. 330-338
    • Anand, P.1    Nair, H.B.2    Sung, B.3    Kunnumakkara, A.B.4    Yadav, V.R.5    Tekmal, R.R.6    Aggarwal, B.B.7
  • 37
    • 77955108815 scopus 로고    scopus 로고
    • Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies
    • Zhao L, Feng SS. Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies. J Pharm Sci. 2010; 99:3552-3560.
    • (2010) J Pharm Sci , vol.99 , pp. 3552-3560
    • Zhao, L.1    Feng, S.S.2
  • 38
    • 84911410432 scopus 로고    scopus 로고
    • Nanoparticles and the mononuclear phagocyte system: pharmacokinetics and applications for inflammatory diseases
    • Song G, Petschauer JS, Madden AJ, Zamboni WC. Nanoparticles and the mononuclear phagocyte system: pharmacokinetics and applications for inflammatory diseases. Curr Rheumatol Rev. 2014; 10:22-34.
    • (2014) Curr Rheumatol Rev , vol.10 , pp. 22-34
    • Song, G.1    Petschauer, J.S.2    Madden, A.J.3    Zamboni, W.C.4
  • 39
    • 0037462992 scopus 로고    scopus 로고
    • PEGylated nanoparticles for biological and pharmaceutical applications
    • Otsuka H, Nagasaki Y, Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev. 2003; 55:403-419.
    • (2003) Adv Drug Deliv Rev , vol.55 , pp. 403-419
    • Otsuka, H.1    Nagasaki, Y.2    Kataoka, K.3
  • 41
    • 70450221930 scopus 로고    scopus 로고
    • Biodegradable polymeric nanoparticles based drug delivery systems
    • Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2010; 75:1-18.
    • (2010) Colloids Surf B Biointerfaces , vol.75 , pp. 1-18
    • Kumari, A.1    Yadav, S.K.2    Yadav, S.C.3
  • 42
    • 84939644520 scopus 로고    scopus 로고
    • Polymeric nanoparticle drug delivery technologies for oral delivery applications
    • Pridgen EM, Alexis F, Farokhzad OC. Polymeric nanoparticle drug delivery technologies for oral delivery applications. Expert Opin Drug Deliv. 2015; 1-15.
    • (2015) Expert Opin Drug Deliv , pp. 1-15
    • Pridgen, E.M.1    Alexis, F.2    Farokhzad, O.C.3
  • 43
    • 33645034817 scopus 로고    scopus 로고
    • Nanoencapsulation, I. Methods for preparation of drug-loaded polymeric nanoparticles
    • Pinto Reis C, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation, I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine. 2006; 2:8-21.
    • (2006) Nanomedicine , vol.2 , pp. 8-21
    • Pinto Reis, C.1    Neufeld, R.J.2    Ribeiro, A.J.3    Veiga, F.4
  • 46
    • 84930456687 scopus 로고    scopus 로고
    • Study the effects of PLGA-PEG encapsulated Amphotericin B nanoparticle drug delivery system against Leishmania donovani
    • Kumar R, Sahoo GC, Pandey K, Das V, Das P. Study the effects of PLGA-PEG encapsulated Amphotericin B nanoparticle drug delivery system against Leishmania donovani. Drug Deliv. 2014; 22:383-388.
    • (2014) Drug Deliv , vol.22 , pp. 383-388
    • Kumar, R.1    Sahoo, G.C.2    Pandey, K.3    Das, V.4    Das, P.5
  • 47
    • 84893210798 scopus 로고    scopus 로고
    • Engineering cells with intracellular agent-loaded microparticles to control cell phenotype
    • Ankrum JA, Miranda OR, Ng KS, Sarkar D, Xu C, Karp JM. Engineering cells with intracellular agent-loaded microparticles to control cell phenotype. Nat Protoc. 2014; 9:233-245.
    • (2014) Nat Protoc , vol.9 , pp. 233-245
    • Ankrum, J.A.1    Miranda, O.R.2    Ng, K.S.3    Sarkar, D.4    Xu, C.5    Karp, J.M.6
  • 48
    • 70349287549 scopus 로고    scopus 로고
    • Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers
    • Hafner A, Lovric J, Voinovich D, Filipovic-Grcic J. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers. Int J Pharm. 2009; 381:205-213.
    • (2009) Int J Pharm , vol.381 , pp. 205-213
    • Hafner, A.1    Lovric, J.2    Voinovich, D.3    Filipovic-Grcic, J.4
  • 49
    • 84883715434 scopus 로고    scopus 로고
    • Selective cytotoxicity, inhibition of cell cycle progression, and induction of apoptosis in human breast cancer cells by sesquiterpenoids from Inula lineariifolia Turcz
    • Qin JJ, Jin HZ, Huang Y, Zhang SD, Shan L, Voruganti S, Nag S, Wang W, Zhang WD, Zhang R. Selective cytotoxicity, inhibition of cell cycle progression, and induction of apoptosis in human breast cancer cells by sesquiterpenoids from Inula lineariifolia Turcz. Eur J Med Chem. 2013; 68:473-481.
    • (2013) Eur J Med Chem , vol.68 , pp. 473-481
    • Qin, J.J.1    Jin, H.Z.2    Huang, Y.3    Zhang, S.D.4    Shan, L.5    Voruganti, S.6    Nag, S.7    Wang, W.8    Zhang, W.D.9    Zhang, R.10
  • 50
    • 84917696389 scopus 로고    scopus 로고
    • RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo
    • Wang W, Cheng J, Qin JJ, Voruganti S, Nag S, Fan J, Gao Q, Zhang R. RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo. Oncotarget. 2014; 5:11604-11619.
    • (2014) Oncotarget , vol.5 , pp. 11604-11619
    • Wang, W.1    Cheng, J.2    Qin, J.J.3    Voruganti, S.4    Nag, S.5    Fan, J.6    Gao, Q.7    Zhang, R.8
  • 51
    • 84927795159 scopus 로고    scopus 로고
    • Development and validation of a rapid HPLC method for quantitation of SP-141, a novel pyrido[b]indole anticancer agent, and an initial pharmacokinetic study in mice
    • Nag S, Qin JJ, Voruganti S, Wang MH, Sharma H, Patil S, Buolamwini JK, Wang W, Zhang R. Development and validation of a rapid HPLC method for quantitation of SP-141, a novel pyrido[b]indole anticancer agent, and an initial pharmacokinetic study in mice. Biomed Chromatogr. 2015; 29:654-663.
    • (2015) Biomed Chromatogr , vol.29 , pp. 654-663
    • Nag, S.1    Qin, J.J.2    Voruganti, S.3    Wang, M.H.4    Sharma, H.5    Patil, S.6    Buolamwini, J.K.7    Wang, W.8    Zhang, R.9
  • 52
    • 84929136393 scopus 로고    scopus 로고
    • A quantitative LC-MS/MS method for determination of SP-141, a novel pyrido[b]indole anticancer agent, and its application to a mouse PK study
    • Nag S, Qin JJ, Patil S, Deokar H, Buolamwini JK, Wang W, Zhang R. A quantitative LC-MS/MS method for determination of SP-141, a novel pyrido[b]indole anticancer agent, and its application to a mouse PK study. J Chromatogr B Analyt Technol Biomed Life Sci. 2014; 969:235-240.
    • (2014) J Chromatogr B Analyt Technol Biomed Life Sci , vol.969 , pp. 235-240
    • Nag, S.1    Qin, J.J.2    Patil, S.3    Deokar, H.4    Buolamwini, J.K.5    Wang, W.6    Zhang, R.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.